An ongoing dialogue on HIV/AIDS, infectious diseases,
April 26th, 2024
Hey, Insurance Companies and Pharmacies — Stop Messing Around with the Price of Cheap Generic Drugs
If you’re practicing medicine these days, you’ve likely experienced some version of this painfully annoying scenario. You prescribe a generic medication, one that’s inexpensive. Your patient goes to the pharmacy, and the pharmacist says that it requires a prior approval. They leave without getting their meds. Here’s a recent example from one of my patients […]
April 8th, 2024
The Rise and Fall of Paxlovid
It’s been quite the ride for our “preferred” outpatient therapy for COVID-19, nirmatrelvir with ritonavir — much better known as Paxlovid, so allow me the license to use the licensed name. Let’s recap the astonishing success and now failure of this intervention (some dates approximate): December 2021, the FDA issued an Emergency Use Authorization for […]